Citius Pharma Inc. is a biopharmaceutical company that specializes in making medical devices for patients with cancer and AIDS.

The company’s stock is currently trading at about $27.75.

The IPO was a major catalyst for Citius, which was founded by Timber Pharmaceuticals CEO Eric Eisenegger.

The startup raised $2 billion in funding, and Citius has raised a total of $19 billion in capital.

In 2017, Citius raised $5 billion from a number of investors, including former Google CEO Sundar Pichai.

Citius currently employs more than 2,300 people worldwide.

The CEO and founder of Citius is Timber, who is also the chairman of the board of directors of the Biomarin Pharmaceuticals Corp. (Biomarin).

Timber was also CEO of BioVironment Inc., an internet security company that was acquired by Google in 2017.

Timber has been an investor in several other companies, including Facebook, Lyft, and Netflix.

He also owns the BioViruses Inc. company.

Citus is owned by Eisener, who also owns BioVirus.

He previously served as CEO of Citus in 2013.

Eisbert has been the CEO of Biomina since 2012, and has held the position since 2014.

Timbrere’s net worth is $5.7 billion.